[The use of antidepressants to treat depression in children and adolescents].
Desombre
H
H
Unité de psychopathologie de l'enfant et de l'adolescent, département de pédiatrie, hôpital Edouard-Herriot, place d'Arsonval 69437 Lyon, cedex 03, France. hugues.desombre@chu-lyon.fr
Paccalin
C
C
Revol
O
O
Fourneret
P
P
D000293:Adolescent; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D017277:Drug Approval; D005602:France; D006801:Humans; D009638:Norepinephrine / Q000378:metabolism; D018570:Risk Assessment; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
D000317:Adrenergic alpha-Antagonists; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D009638:Norepinephrine; D017367:Selective Serotonin Reuptake Inhibitors